JP2014529406A5 - - Google Patents

Download PDF

Info

Publication number
JP2014529406A5
JP2014529406A5 JP2014528501A JP2014528501A JP2014529406A5 JP 2014529406 A5 JP2014529406 A5 JP 2014529406A5 JP 2014528501 A JP2014528501 A JP 2014528501A JP 2014528501 A JP2014528501 A JP 2014528501A JP 2014529406 A5 JP2014529406 A5 JP 2014529406A5
Authority
JP
Japan
Prior art keywords
bone
pvmcs
composition
isolated
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014528501A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014529406A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2014529406A publication Critical patent/JP2014529406A/ja
Publication of JP2014529406A5 publication Critical patent/JP2014529406A5/ja
Pending legal-status Critical Current

Links

JP2014528501A 2011-08-29 2012-08-27 血管周囲薬用細胞の単離および治療的使用 Pending JP2014529406A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201161528556P 2011-08-29 2011-08-29
US201161528563P 2011-08-29 2011-08-29
US201161528567P 2011-08-29 2011-08-29
US61/528,556 2011-08-29
US61/528,563 2011-08-29
US61/528,567 2011-08-29

Publications (2)

Publication Number Publication Date
JP2014529406A JP2014529406A (ja) 2014-11-13
JP2014529406A5 true JP2014529406A5 (enExample) 2015-10-29

Family

ID=47756794

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014528501A Pending JP2014529406A (ja) 2011-08-29 2012-08-27 血管周囲薬用細胞の単離および治療的使用

Country Status (7)

Country Link
US (1) US20140314869A1 (enExample)
EP (1) EP2751256A4 (enExample)
JP (1) JP2014529406A (enExample)
AU (1) AU2012300221A1 (enExample)
CA (1) CA2853910A1 (enExample)
SG (1) SG11201401038VA (enExample)
WO (1) WO2013033043A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10758573B2 (en) 2015-06-09 2020-09-01 President And Fellows Of Harvard College Compositions and methods for enrichment of cells
CN105505862B (zh) * 2015-12-29 2019-01-18 江苏省原子医学研究所 一种采用机械分离法提取骨组织中的成骨细胞的方法
AU2018283372B2 (en) 2017-06-16 2024-06-13 Avery Therapeutics, Inc. Three dimensional tissue compositions and methods of use
CN111601606A (zh) 2017-11-29 2020-08-28 菲格内有限责任公司 用于活化的成纤维细胞与免疫细胞的相互作用及其用途
WO2020092321A1 (en) * 2018-10-29 2020-05-07 Avery Therapeutics, Inc. Compositions and methods for cryopreservation and reconstitution of engineered tissues
EP3921029B1 (en) * 2019-02-07 2025-07-30 Baylor College of Medicine Composition comprising ccl5 for use in treating bone break, bone fracture, bone degeneration and osteoporosis
CN115772494B (zh) * 2021-09-06 2025-10-21 上海交通大学医学院附属第九人民医院 一种牙槽骨组织消化液及其在牙槽骨细胞分离中的用途和方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619989A (en) * 1981-05-05 1986-10-28 The Regents Of The University Of Cal. Bone morphogenetic protein composition
AU2003901668A0 (en) * 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
US20030095993A1 (en) * 2000-01-28 2003-05-22 Hanne Bentz Gel-infused sponges for tissue repair and augmentation
GB0600972D0 (en) * 2006-01-18 2006-03-01 Univ Leeds Enrichment of cells
US20070264239A1 (en) * 2006-05-10 2007-11-15 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Isolation of pericytes
EP2288359B1 (en) * 2008-04-21 2019-10-02 Tissue Regeneration Therapeutics Inc. Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
US8470308B2 (en) * 2009-01-03 2013-06-25 Ray C. Wasielewski Enhanced medical implant comprising disrupted tooth pulp and tooth particles
US20120148546A1 (en) * 2009-08-17 2012-06-14 Technion Research & Development Foundation Ltd. Pericyte progenitor cells and methods of generating and using same

Similar Documents

Publication Publication Date Title
JP2014529406A5 (enExample)
CN110499287B (zh) 简易制备胎盘间充质干细胞外泌体的方法
Jones et al. Large‐scale extraction and characterization of CD271+ multipotential stromal cells from trabecular bone in health and osteoarthritis: implications for bone regeneration strategies based on uncultured or minimally cultured multipotential stromal cells
Uth et al. Stem cell application for osteoarthritis in the knee joint: A minireview
EP3037523B1 (en) Production method and cryopreservation method for amniotic mesenchymal cell composition, and therapeutic agent
Froelich et al. Chromosomal aberrations and deoxyribonucleic acid single-strand breaks in adipose-derived stem cells during long-term expansion in vitro
KR20180123054A (ko) 매트릭스가 결합된 나노소낭 및 그의 용도
JP2009523438A5 (enExample)
WO2014203267A2 (en) Method for isolation, purification and industrial scale expansion of human adipose tissue derived mesenchymal stem cells
CN104818264A (zh) 一种消化酶组合物及其制剂、应用
Manferdini et al. Lack of anti-inflammatory and anti-catabolic effects on basal inflamed osteoarthritic chondrocytes or synoviocytes by adipose stem cell-conditioned medium
CN108588026A (zh) 高表达il10的临床级间充质干细胞的制备方法及其用途
US11510946B2 (en) Treatment of multiple sclerosis with adipose-derived stem cells
CA2853910A1 (en) Isolating and therapeutic use of perivascular medicinal cells
Wang MSCs transplantation may be a potential therapeutic strategy for COVID-19 treatment
KR101178032B1 (ko) 지방줄기세포 파쇄 추출액을 이용한 모발증식제재 및 이의 제조방법
Briquet et al. RETRACTED: human bone marrow, umbilical cord or liver mesenchymal stromal cells fail to improve liver function in a model of CCl4-induced liver damage in NOD/SCID/IL-2Rγ (null) mice
US12241088B2 (en) Uterine-derived regenerative cell compositions and uses thereof
JPWO2020214400A5 (enExample)
Tandon et al. Dental pulp stem cells from primary and permanent teeth: quality analysis
CN113662970A (zh) 一种脐带干细胞制剂在制备治疗骨关节炎药物中的应用
He et al. Lentivirus transduced interleukin‑1 receptor antagonist gene expression in murine bone marrow‑derived mesenchymal stem cells in vitro
Balderrama et al. CLINICAL APPLICATIONS FOR ORAL BONE REGENERATION WITH MESENCHYMAL STEM CELLS FROM ADIPOSE TISSUE: WHAT ARE THE LEVELS OF SCIENTIFIC EVIDENCE?
US12497594B2 (en) Uterine-derived regenerative cell compositions and uses thereof
Lee et al. Therapeutic possibility of human fetal cartilage-derived progenitor cells in rat arthritis model